Agilent Technologies supports proteomics research

Agilent Technologies has announced that Steven Carr, PhD, director of the Proteomics Platform at the Broad Institute of MIT and Harvard, has been selected for an Agilent Thought Leader award supporting his work developing new technology for analysing proteins and peptides. The award, which promotes fundamental advances in the life sciences, includes Agilent funding and donation of an automated liquid-handling system, a chip-based nano-HPLC system and a triple quadrupole liquid chromatography/mass spectrometry system.

“There is a great need for better tools to measure proteins with greater selectivity and sensitivity for improved quantitative accuracy. This is why we’re pleased to support Steve Carr’s promising work,” said vice president and general manager of Agilent’s LC-MS business, John Fjeldsted, PhD.

Carr’s goal is to produce better techniques for diagnosing cardiovascular disease, breast cancer and ovarian cancer. “This award will allow us to explore new automation methods for liquid handling and sample preparation together with high-sensitivity targeted, quantitative mass spectrometry,” Carr said.

The key goal is to replace expensive, labour-intensive methods involving scarce immunoassay-grade antibody reagents with more efficient, cost-effective techniques that can be multiplexed and that require very small quantities of precious samples. The use of automated robotics for sample preparation via liquid handling is one of the keys to this.

For more information, visit ref="http://www.agilent.com">www.agilent.com